Publication and related biases

Health Technology Assessment

Volumn 4, Issue 10, 2000, Pages

  Song, F ^a   Eastwood, A J ^a   Gilbody, S ^a   Duley, L ^a   Sutton, A J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DATA ANALYSIS; MEDICAL LITERATURE; PEER REVIEW; PUBLICATION; REVIEW;

EID: 0033874888     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta4100     Document Type: Review

References (359)

1. Rationale for systematic reviews
2. Bias in meta analytic research
3. The 'file drawer problem' and tolerance for null results
4. The iceberg phenomenon and publication bias - the editor's fault?
5. Publication bias: A problem in interpreting medical data
6. Publication decisions and their possible effects on inferences drawn from tests of significance - or vice versa
7. A note on fatality in serum hepatitis
8. Testicular size and shape of 47,XYY and 47,XXY men in a double-blind, double-matched population survey
9. Confronting publication bias: A cohort design for meta analysis
10. Increase in studies of publication bias coincided with increasing use of meta-analysis
11. A dictionary of epidemiology. 3rd ed.
12. Minimizing the three stages of publication bias
13. The existence of publication bias and risk factors for its occurrence
14. Confusion about 'negative' studies
15. What is publication
16. Bias in analytic research
17. Publication bias, retrieval bias and pipeline effects. Discussion of the paper by Begg and Berlin
18. The randomized controlled trial gets a middle-aged checkup
19. 'Place of publication' bias [letter]?
20. Impact of covert duplicate publication on meta-analysis: A case study
21. Selecting the language of the publications included in a meta-analysis: Is there a tower of babel bias?
22. Reference bias in reports of drug trials
23. Publications bias and the evaluation of psychotherapy efficacy in reviews of the research literature
24. Publication decisions revisited - The effect of the outcome of statistical tests on the decision to publish and vice-versa
25. The importance of negative results in psychological research
26. Signifying significant significance
27. Publication bias against null results
28. Consequences of prejudice against the null hypothesis
29. Source of funding and outcome of clinical trials
30. Positive-outcome bias: Comparison of emergency medicine and general medicine literatures
31. Statistical power, sample size, and their reporting in randomized controlled trials
32. Sample-size of randomized double-blind trials 1976-1991
33. The file drawer problem of nonsignificant results - Does it apply to biological research?
34. Is there a 'file drawer problem' in biological research?
35. An assessment of publication bias using a sample of published clinical trials
36. Discussion of the paper by Begg and Berlin: Publication bias: A problem in interpreting medical data
37. Publication bias in obesity treatment trials
38. Misleading meta-analysis: Lessons from 'an effective, safe, simple' intervention that wasn't
39. Where next for prophylaxis against pre-eclampsia?
40. Bias in meta-analysis detected by a simple, graphical test
41. Publication bias and clinical trials
42. Publication practices and the file drawer problem - A survey of published authors
43. Effect of positive findings on submission and acceptance rates: A note on meta-analysis bias
44. The file drawer effect and publication rates in menstrual cycle research
45. How many studies are in the file drawer - An estimate from the family marital psychotherapy literature
46. Retrospective and prospective identification of unpublished controlled trials: Lessons from a survey of obstetricians and pediatricians
47. Publication bias in clinical research
48. Factors influencing publication of research results. Follow up of applications submitted to two institutional review boards
49. NIH clinical trials and publication bias
50. Publication bias: Evidence of delayed publication in a cohort study of clinical research projects
51. How important is publication bias? A synthesis of available data
52. Publication bias: The case for an international registry of clinical trials
53. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials
54. Publication bias and research on passive smoking. Comparison of published and unpublished studies
55. Meta-analyses of randomised controlled trials
56. Publication bias and meta-analysis
57. The relation between socioeconomic status and academic achievement
58. Perioperative parenteral nutrition: A meta-analysis
59. Empirical assessment of publication bias: Lessons from two meta-analyses
60. Unpublished data from United States Food and Drug Administration New Drug Application Reviews: How do they compare to published data when assessing nonsteroidal antiinflammatory drug (NSAID) associated dyspepsia [Abstract]
61. Evaluation of the impact of grey literature on meta-analysis
62. Full publication of results initially presented in abstracts. A meta-analysis
63. The fate of abstracts submitted to a cancer meeting: Factors which influence presentation and subsequent publication
64. A cohort study of summary reports of controlled trials
65. The publication outcome for the papers presented at the 1990 ABA conference
66. Time to publication as full reports of abstracts of randomized controlled trials in cystic fibrosis
67. Unpublished research from a medical specialty meeting. Why investigators fail to publish
68. Lost information: The fate of papers presented at the 40th Society for Social Medicine Conference
69. Fate of cardiology research originally published in abstract form
70. A survey of the publication history of randomly selected IADR/AADR abstracts presented in 1983 and 1984
71. Pattern of publication of ophthalmic abstracts in peer-reviewed journals
72. Publication of research presented at the pediatric meetings. Change in selection
73. Publications resulting from anesthesia meeting abstracts
74. Published or perished: What becomes of papers presented at Oncology Nursing Society Congresses?
75. Surgical research: Master of servant
76. Publication of patient-related oncology nursing research
77. Publication of abstracts presented at anaestheia meetings
78. Publication patterns of presentations at the Society of Teachers of Family Medicine and North American Primary Care Research Group annual meetings
79. Publication pattern of papers presented at the American Society for Surgery of the Hand annual
80. Bias against the null hypothesis: The reproductive hazards of cocaine
81. Positive-outcome bias and other limitations in the outcome of research abstracts submitted to a scientific meeting
82. Agreement of data in abstracts compared to full publications
83. Differences between information provided in abstract of randomized controlled trials in neonates submitted to the annual meeting of the American Pediatric Research (APS/SPR) and final publications - implications for meta-analyses
84. Sponsored symposia on environmental tobacco smoke
85. Publication bias in statistical overview of trials: Example of psychological rehabilitation following myocardial infarction
86. Statistical problems in the reporting of clinical trials. A survey of three medical journals
87. False-positive results in clinical trials: Multiple significance tests and the problem of unreported comparisons
88. Redundant publication in biomedical sciences: Scientific misconduct or necessity?
89. Repetitive publication: A waste that must stop
90. Duplicate publication on post-menopausal bone loss
91. Notice of duplicate publication
92. Unfortunately, more on duplicate publication
93. Redundant publication
94. Sole contribution
95. Multiple publication of reports of drug trials
96. Infertility treatment: From cookery to science. The epidemiology of randomised controlled trials
97. Redundancy, disaggregation, and the integrity of medical research
98. On not being born a native speaker of English
99. Publish in English, or perish?
100. National publication bias
101. National publication bias
102. Multiple blinded reviews of the same two manuscripts. Effects of referee characteristics and publication language
103. Language bias in randomised controlled trials published in English and German
104. Efficacy of spinal manipulation/mobilization therapy. A meta-analysis
105. Do certain countries produce only positive results? A systematic review of controlled trials
106. Review of randomised controlled trials of traditional Chinese medicine
107. Bias in location and selection of studies
108. New equities of information in an electronic age. The third world needs first world information - How about the other way round?
109. Bias against European journals in medical publication databases
110. Perusing the literature: Comparison of MEDLINE searching with a perinatal trials database
111. The retrieval of randomized clinical trials in liver diseases from the medical literature: Manual versus MEDLARS searches
112. Searching MEDLINE for randomised clinical trials involving care of the newborn
113. Comparison of search strategies for recalling double-blind trials from Medline
114. The comprehensiveness of MEDLINE and EMBASE computer searches. Searches for controlled trials of homoeopathy, ascorbic acid for common cold and ginkgo biloba for cerebral insufficiency and intermittent claudication
115. Developing a register of randomised controlled trials in primary care
116. A high-yield strategy to identify randomized controlled trials for systematic reviews
117. An investigation of the adequacy of Medline searches for randomized controlled trials (RCTs) on the effects of mental health care
118. The use of 'grey literature' in a sub-set of neurological Cochrane reviews
119. Searching the right database. A comparison of four databases for psychiatry journals
120. Private acts and public objects: An investigation of citer motivations
121. Author judgements about works they cite; Three studies from psychology journals
122. The citation bias - fad and fashion in the judgement and decision literature
123. Is there a citation bias in the judgment and decision literature?
124. Cholesterol lowering trials in coronary heart disease: Frequency of citation and outcome
125. Quotation bias in reviews of the diet-heart idea
126. Comprehensiveness and bias in reporting clinical trials. Study of reviews of pneumococcal vaccine effectiveness
127. Prophylactic removal of impacted third molars: An assessment of published reviews
128. Reviewing the reviews. The example of chronic fatigue syndrome
129. Phenomena of retraction. Reasons for retraction and citations to the publications
130. What is newsworthy?
131. Causes of death: Biased newspaper coverage and biased judgments
132. The association between alcohol and breast cancer popular press coverage of research
133. Bias against negative studies in newspaper reports of medical research
134. Mortality among workers at Oak Ridge National Laboratory
135. Cancer in populations living near nuclear facilities: A survey of mortality nationwide and incidence in two states
136. Under-reporting research in scientific misconduct
137. The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction - an example of publication bias
138. Preliminary report: Effect of encainide and flecainide on mortality in a randomised trial of arrhythmia suppression after myocardial infarction
139. Effect of the antiarrhythmic agent moricisine on survival after myocardial infarction
140. Scientists who do not publish trial results are 'unethical'
141. Intravenous magnesium in acute myocardial infarction: An effective, safe, simple, and inexpensive intervention
142. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with acute myocardial infarction
143. The risk epidemic in medical journals
144. Clinical research - What should the public believe?
145. Epidemiology faces its limits
146. Biases in the interpretation and use of research results
147. Publication bias in two Spanish medical journals. (The International Congress on Biomedical Peer review and Global Communications. Prague, 1997)
148. A systematic review of the risk of stroke and death due to endarterectomy for symptomatic carotid stenosis
149. Authors' criteria for selecting journals
150. Withholding research results in academic life science
151. A survey of attitudes and behaviors of authors who publish in psychology and education journals
152. Manuscript characteristics which influence acceptance for management and social science journals
153. View
154. Peer review: Crude and understudied, but indispensable
155. Peer review is an effective screening processes to evaluate medical manuscripts
156. Guidelines for publishing papers on cancer clinical trials: Responsibilities of editors and authors
157. Manuscript guidelines
158. Negative studies
159. Journal peer review: The Need for a research agenda
160. Bias, subjectivity, chance, and conflict of interest in editorial decisions
161. Publication prejudices: An experimental study of confirmatory bias in the peer review system
162. Reviewer bias - A blinded experimental study
163. Confirmation response bias among social work journals
164. Publication bias: Direction of outcome less important than scientific quality
165. Does peer review favor the conceptual framework of orthodox medicine? A randomized controlled study. (The International Congress on Biomedical Peer Review and Global Communications. Prague, 1997.)
166. Peer-reviewer bias against unconventional medicine? (The International Congress on Biomedical Peer Review and Global Communications. Prague 1997.)
167. Effect of institutional prestige on reviewers' recommendations and editorial decisions
168. Review of the reviewer
169. Do readers and peer reviewers agree on manuscript quality?
170. Relationships between academic institutions and industry in the life sciences - An industry survey
171. Industrial support of university research in biotechnology
172. Participation of life-science faculty in research relationships with industry
173. Secrecy in medical research
174. Study of information submitted by drug companies to licensing authorities
175. Report bias in drug research
176. Bias in reporting clinical trials
177. Too soon to market: Doctors and patients need more information before drugs enter routine use
178. Secrecy and transparency of medicines licensing in the EU
179. Intellectual property, drug licensing, freedom of information, and public health
180. Thyroid storm
181. Withholding unfavourable results in drug company sponsored clinical trials
182. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism
183. Plagiarism or protecting public health
184. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis
185. Conflict of interest in the debate over calcium-channel antagonists
186. Conflict of interest in the debate over calcium-channel antagonists
187. Conflict of interest in the debate over calcium-channel antagonists
188. Conflict of interest in the debate over calcium-channel antagonists
189. Conflict of interest in the debate over calcium-channel antagonists
190. Beyond conflict of interest: Transparency is the key
191. Industry-funded research and conflict of interest: An analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research
192. The quality of drug studies published in symposium proceedings
193. Estimating effect size: Bias resulting from the significance criterion in editorial decisions
194. Estimation of effect size under nonrandom sampling: The effects of censoring studies yielding statistically insignificant mean differences
195. Publication bias
196. Publication bias and dissemination of clinical research
197. Meta-analytic methods for diagnostic test accuracy
198. Discussion of the paper by Begg and Berlin: Publication bias: A problem in interpreting medical data
199. Meta-analysis and the meta-epidemiology of clinical researh. Registration of trials should be required by editors and registering agencies
200. An amnesty for unpublished trials: Send us details on any unreported trials
201. Medical editor's trial amnesty
202. Too many hoops?
203. 50 years of reporting of randomised controlled trials in general health care journals worldwide: How things have changed
204. The effectiveness of editorial peer review
205. Readers' evaluation of effect of peer review and editing on quality of articles in the Nederlands Tijdschrift voor Geneeskunde
206. The future of peer review
207. A citation analysis of the impact of blinded peer review
208. Effect on the quality of peer review of blinding reviewers and asking them to sign their reports
209. Effect of blinding and unmasking on the quality of peer review. A randomized trial
210. How blind is blind review?
211. The effects of blinding on the quality of peer review: A randomized trial
212. Masking author identity in peer review. What factors influence masking success?
213. Does masking author identity improve peer review quality? A randomized controlled trial
214. Freedom and responsibility in medical publication. Setting the balance right
215. Opening up BMJ peer review: A beginning that should lead to complete transparency
216. Electronic publishin in the health sciences
217. The electronic future: What might an online scientific paper look like in five years' time [Editorial]?
218. The elecrtronic future of scientific articles
219. The future of medical journals in the western world
220. Electronic database and the scientific record
221. A trial bank model for the publication of clinical trials
222. Pleasing both authors and readers: A combination of short print articles and longer electronic ones may help us do this
223. How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing
224. Will publication bias vanish in the age of online journals?
225. Meta-analysis and the meta-epidemiology of clinical research: Meta-analysis is an important contribution to research and practice but it's not a panacea
226. The role of electronic journals in reducing publication bias
227. Current Controlled Trials. Ways and means of registering controlled trials
228. Position paper and consensus recommendation on clinical trial registries
229. Keeping posted. Why register clinical trials? - revisited
230. Directory of registries of clinical trials
231. UKCCCCR Register of UK cancer trials
232. Prospectively identified trials could be used for comparison with meta-analyses
233. Review articles and publication bias
234. Registry of prospective clinical trials second report
235. The Ottawa Stroke Trials Registry Collaborative Group and the Development of the Ottawa Stroke Trials Registry (OSTR)
236. The Cochrane database of systematic reviews
237. The WHO global programme for vaccines and immunizaton vaccine trial registry
238. Protocol for a prospectie collaborative overview of all current and planned randomized trials of cholesterol treatment regimens
239. Prospective meta-analysis of cholesterol-lowering studies - the prospective pravastatin pooling (Ppp) project and the Cholesterol Treatment Trialists (Ctt) Collaboration
240. Toward Prospective registration of clinical trials
241. Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability
242. Regulatory process effects clinical trial registration in Spain
243. A registry for clinical trials
244. Registering clinical trials
245. Report from the panel on the case for registers of clinical trials at the eighth annual meeting of the Society for Clinical Trials
246. Registry of multicenter clinical trials: 14th and 15th report 1992-1993
247. International collaboration in trial registration
248. Freedom of information, when it suits
249. Freedom of information
250. Bioequivalence of levothyroxine preparations: Industry sponsorship and academic freedom
251. Large-scale randomized evidence: Large, simple trials and overviews of trials
252. Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials
253. Predictive ability of meta-analyses of randomized controlled trials
254. Large trials vs meta-analysis of smaller trials. How do their results compare?
255. Discrepancies between meta-analyses and subsequent large randomized, controlled trials
256. Issues in comparisons between meta-analyses and large trials
257. Do small trials square with large ones?
258. The effect of a multiple literature database - A numerical evaluation in the domain of Japanese life science
259. Using the Cochrane Controlled Clinical Trials Register (CENTRAL) to identify clinical trials in selected medical fields
260. Review of the usefulness of contacting other experts when conducting a literature search for systematic reviews
261. Comparison of literature searches on quality and costs for health technology assessment using the Medline and Embase databases
262. Guides for reading and interpreting systematic reviews. II: How did the authors find the studies and assess their quality?
263. Should unpublished data be included in meta analyses? Current convictions and controversies
264. Data on file cited in pharmaceutical advertisements: What are they? (The International Congress on Biomedical Peer Review and Global Communications. Prague, 1997)
265. Meta-analysis: Unresolved issues and future developments
266. Cochrane reviewers' handbook
267. Trim and fill: A simple funnel plot based method of adjusting for publication bias in meta-analysis
268. Models for estimating the number of unpublished studies
269. Total parenteral nutrition and cancer clincial trials
270. Statistician's comments on: 'Fail safe N' is a useful mathematical measure of the stability of results
271. Operating characteristics of a rank correlation test for publication bias
272. A note of graphical presentation of estimated odds ratios from several clinical trials
273. Selection models and the file drawer problem
274. Modelling publication selection effects in meta-analysis
275. An approach for assessing publication bias prior to performing a meta-analysis
276. A general linear model for estimating effect size in the presence of publication bias
277. An application of Gibbs sampling to estimation in meta-analysis: Accounting for publication bias
278. Publication bias in meta-analysis: A Bayesian data-augmentation appraoch to account for issues exemplified in the passive smoking debate
279. What works? Selectivity models and meta-analysis
280. Estimating effect size under publication bias: Small sample properties and robustness of a ransom effects selection model
281. Are the clinical effects of homoeopahty placebo effects? A meta-analysis of lacebo-controlled trials
282. Detecting and adjusting for publication bias in meta-analysis: A systematic review
283. Meta-analysis: Weighing the evidence
284. A comparison of statistical methods for combining event rates from clinical trials
285. Invited commentary: A critical look at some popular meta-analytic methods
286. Methodology and reports of systematic reviews and meta-analyses. A comparison of Cochrane reviews with articles published in paper-based journals
287. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: A meta-analysis
288. Cervical cancer (cervix uteri)
289. Uterine cancer
290. Ovarian cancer
291. The role of grey literature in meta-analysis. (The International Congress on Biomedical Peer Review and Global Communications. Prague, 1997)
292. Poorly executed and inadequately documented? An analysis of the literature searches on which systematic reviews are based
293. Discussion of the paper by Begg and Berlin: Publication bias: A problem in interpreting medical data
294. Discussion of the paper by Begg and Berlin: Publication bias: A problem in interpreting medical data
295. Is publication bias a medical problem [Letter]?
296. Publication bias
297. When is a negative study not negative?
298. Methodological studies of systematic reviews: Is there publication bias [Letter]?
299. Publication bias
300. Toward an ethic in dissemination of new knowledge in primary care research
301. Publication of research: The ethical dimension
302. Playing fair: Science, ethics and scientific journals
303. Proposal to outlaw the term 'negative trial'
304. 'Negative trials' are positive!
305. Eureka: It's a negative study
306. Assessing publication bias, and the importance of study quality: The quality adjusted funnel plot
307. Can we detect the presenc of publication and related biases? Simulation studies and illustrative examples from the literature
308. Stochastic simulation and sensitivity analysis: Estimating future demand for health resources in China
309. Towards an international register of cancer trials: The UKCCCR register of UK trials
310. Registry of clincial trials of antithrombotic drugs in cancer: Second report
311. Registry of clinical trials of antithrombotic drugs in cancer
312. Development of a prospective register of smoking cessation trials
313. Improving communications in clincial oncology: The EuroCODE Project. The EuroCODE Steering Committee
314. Probing encountered data, meta-analysis and weighted distribution methods
315. Estimating publication bias in meta-analysis
316. Modeling publication bias using weighted distributions in a Bayesian framework
317. Non-parametric classes of weight functions to model publication bias
318. Hierarchical selection models with applications in meta-analysis
319. Estimating the normal mean and variance under a publication selection model
320. Random effects models
321. Assessing the effects of selection bias on validity data for the general aptitude test battery
322. Systematic reviews of trials and other studies
323. Meta-analysis in practice: A critical review of available software
324. Oral contraceptives and cnacer of the cervix uteri - A meta-analysis
325. Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists
326. Assessing the quality of reports of randomised controlled trials: Implications for the conduct of meta-analyses
327. Inference for non-random samples
328. The effects of unrepresented studies on the robustness of validity generalization results
329. Monte Carlo sampling methods using Markov chains and their applications
330. Estimating a summarized odds ratio whilst eliminating publication bias in meta-analysis
331. Publication probability of a study on odds ratio value circumstantial evidence for publication bias in medical study areas